These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7447132)

  • 61. Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
    Liska DA; Akucewich LH; Marsella R; Maxwell LK; Barbara JE; Cole CA
    Am J Vet Res; 2006 Sep; 67(9):1621-7. PubMed ID: 16948611
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses.
    Kuroda T; Nagata S; Takizawa Y; Tamura N; Kusano K; Mizobe F; Hariu K
    Vet J; 2013 Aug; 197(2):433-7. PubMed ID: 23489843
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of gastrointestinal tract disease on pharmacokinetics of lidocaine after intravenous infusion in anesthetized horses.
    Feary DJ; Mama KR; Thomasy SM; Wagner AE; Enns RM
    Am J Vet Res; 2006 Feb; 67(2):317-22. PubMed ID: 16454639
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of luxabendazole after oral and intravenous administration to sheep.
    Ortiz AI; Alvarez-Bujidos L; Ferre I; Ordóñez D
    Am J Vet Res; 1997 Nov; 58(11):1263-6. PubMed ID: 9361890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics and body fluid and endometrial concentrations of cephapirin in mares.
    Brown MP; Gronwall RR; Houston AE
    Am J Vet Res; 1986 Apr; 47(4):784-8. PubMed ID: 3963579
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetics and pharmacodynamics of epsilon-aminocaproic acid in horses.
    Ross J; Dallap BL; Dolente BA; Sweeney RW
    Am J Vet Res; 2007 Sep; 68(9):1016-21. PubMed ID: 17764418
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of changes in urine pH on plasma pharmacokinetic variables of ampicillin sodium in horses.
    Sarasola P; Horspool LJ; McKellar QA
    Am J Vet Res; 1992 May; 53(5):711-5. PubMed ID: 1326242
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma and synovial fluid kinetics, disposition, and urinary excretion of naproxen in horses.
    Soma LR; Uboh CE; Rudy JA; Perkowski SZ
    Am J Vet Res; 1995 Aug; 56(8):1075-80. PubMed ID: 8533980
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
    Bendayan R; McKenzie MW
    Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration.
    Shilo Y; Britzi M; Eytan B; Lifschitz T; Soback S; Steinman A
    J Vet Pharmacol Ther; 2008 Feb; 31(1):60-5. PubMed ID: 18177320
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics and interactions of digoxin with phenobarbital in dogs.
    Ravis WR; Pedersoli WM; Turco JD
    Am J Vet Res; 1987 Aug; 48(8):1244-9. PubMed ID: 3631715
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Body fluid concentrations and pharmacokinetics of chloramphenicol given to mares intravenously or by repeated gavage.
    Gronwall R; Brown MP; Merritt AM; Stone HW
    Am J Vet Res; 1986 Dec; 47(12):2591-5. PubMed ID: 3800117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
    Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
    J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
    Womble AY; Giguère S; Lee EA; Vickroy TW
    Am J Vet Res; 2006 Oct; 67(10):1681-6. PubMed ID: 17014316
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of recombinant interleukin-2 pretreatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice.
    Castagne V; Bonhomme-Faivre L; Urien S; Ben Reguiga M; Soursac M; Gimenez F; Farinotti R
    Drug Metab Dispos; 2004 Feb; 32(2):168-71. PubMed ID: 14744937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.